Discover
ANIP
ANI Pharmaceuticals, Inc.
74.47
2 x 74.34
3 x 74.60
bid
ask
-
1.29
1.70%
01:35 PM
timesize
| Ytd | -5.66% | |
| 1y | -12.26% |
74.34
day range
76.33
70.15
52 week range
99.50
| Open | 75.92 | Prev Close | 75.76 | Low | 74.34 | High | 76.33 | Mkt Cap | 1.69B |
| Vol | 185.24K | Avg Vol | 335.11K | EPS | 8.22 | P/E | 9.06 | Forward P/E | 7.41 |
| Beta | 0.44 | Short Ratio | 9.99 | Inst. Own | 111.87% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 80.80 | 200-d Avg | 80.84 | 1yr Est | 108.38 |
| Income Statement | |||
| Total Revenue | 266.04M | ||
| Revenues (USD) | 266.04M | ||
| Cost of Revenue | 100.16M | ||
| Gross Profit | 165.89M | ||
| Operating Expenses | 126.05M | ||
| Research and Development Expense | 14.75M | ||
| Selling, General and Administrative Expense | 91.66M | ||
| Operating Income | 39.84M | ||
| Interest Expense | 3.64M | ||
| Income Tax Expense | 12.39M | ||
| Net Income | 24.71M | ||
| Net Income Common Stock | 24.71M | ||
| Net Income Common Stock (USD) | 24.71M | ||
| Consolidated Income | 24.71M | ||
| Earnings per Basic Share | 1.09 | ||
| Earnings per Basic Share (USD) | 1.09 | ||
| Earnings per Diluted Share | 1.05 | ||
| Earning Before Interest & Taxes (EBIT) | 40.73M | ||
| Earning Before Interest & Taxes (USD) | 40.73M | ||
| Weighted Average Shares | 21.92M | ||
| Weighted Average Shares Diluted | 21.92M | ||
| Balance Sheet | |||
| Cash and Equivalents | 360.25M | ||
| Cash and Equivalents (USD) | 360.25M | ||
| Investments | 15.63M | ||
| Investments Current | 15.63M | ||
| Trade and Non-Trade Receivables | 274.47M | ||
| Current Assets | 825.43M | ||
| Property, Plant & Equipment Net | 73.22M | ||
| Total Assets | 1.49B | ||
| Debt Current | 21.33M | ||
| Total Debt | 610.49M | ||
| Current Liabilities | 283.65M | ||
| Debt Non-Current | 589.16M | ||
| Total Liabilities | 896.90M | ||
| Accumulated Retained Earnings (Deficit) | 31.10M | ||
| Accumulated Other Comprehensive Income | -327.00K | ||
| Shareholders Equity | 597.21M | ||
| Shareholders Equity (USD) | 597.21M | ||
| Assets Non-Current | 668.68M | ||
| Total Debt (USD) | 610.49M | ||
| Goodwill and Intangible Assets | 512.34M | ||
| Inventory | 143.15M | ||
| Liabilities Non-Current | 613.25M | ||
| Trade and Non-Trade Payables | 73.83M | ||
| Tax Assets | 71.50M | ||
| Tax Liabilities | 3.53M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 20.10M | ||
| Net Cash Flow from Financing | -4.65M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 49.04M | ||
| Capital Expenditure | -3.05M | ||
| Issuance (Purchase) of Equity Shares | -505.00K | ||
| Issuance (Repayment) of Debt Securities | -4.06M | ||
| Net Cash Flow from Investing | -3.05M | ||
| Net Cash Flow from Operations | 56.67M | ||
| Effect of Exchange Rate Changes on Cash | 67.00K | ||
| Share Based Compensation | 11.41M | ||